Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11179328
Compositions and methods for the treatment of presbyopia
granted -
US 11179370
Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers
granted -
CA 3172874
COMPOSITIONS DE POLYPEPTIDES DE FUSION D'IL-2 ET LEURS PROCEDES DE FABRICATION ET D'UTILISATION
granted -
CA 3177686
COMPOSITIONS COMPRENANT DE LA TROPOELASTINE RETICULEE A DE L'ACIDE HYALURONIQUE ET LEURS PROCEDES D'UTILISATION
granted -
CA 3172871
COMPOSITIONS DE POLYPEPTIDES DE FUSION D'IL-2 ET LEURS PROCEDES DE FABRICATION ET D'UTILISATION
granted -
CA 3172190
COMPOSITION COMPRENANT DU METHYLFOLATE
granted -
CA 3177888
ANTICORPS ANTI-HEMOJUVELINE (HJV) DE TRAITEMENT DE L'ANEMIE DE MALADIES CHRONIQUES
granted -
US 11174272
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
granted -
US 11174232
Substituted heterocyclyl derivatives as CDK inhibitors
granted -
US 11173318
Method of repairing age and disease immune dysfunction and cellular senescence with lymphoid stem cells and then re-applying those for therapeutic use
granted -
US 11173173
Methods for treating chemoresistant cancer-initiating cells
granted -
US 11173118
Emulsion formulations of an NK-1 receptor antagonist and uses thereof
granted -
US 11174316
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof
granted -
US 11174292
Substitutions-modified prefusion RSV F proteins and their use
granted -
US 11173146
Selective activators of the intermediate conductance CA2+activated K+ channel KCa3.1 and their methods of use
granted -
US 11174495
Reporter system for detecting and targeting activated cells
granted -
US 11174291
Silstatin compounds
granted -
US 11174514
Methods, kits, and devices utilizing HTR2C polymorphisms for diagnosing, prognosing, and treating psychiatric disorders in a patient
granted -
US 11174320
HER3 specific monoclonal antibodies for diagnostic and therapeutic use
granted -
US 11174305
Human antibodies to Fel d1 and methods of use thereof
granted -
US 11174469
Materials and methods for treatment of Amyotrophic Lateral Sclerosis (ALS) and other related disorders
granted -
US 11174301
Peptide compound
granted -
US 11173227
Wound dressings and applications thereof
granted -
US 11174288
Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.